RO 7119929
Alternative Names: RG 6115; RO-7119929Latest Information Update: 28 Aug 2023
At a glance
- Originator Roche
- Class Antineoplastics; Small molecules
- Mechanism of Action Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
- Discontinued Liver cancer
Most Recent Events
- 28 Aug 2023 No recent reports of development identified for phase-I development in Solid-tumours(Inoperable/Unresectable, Late-stage disease, Metastatic disease) in Denmark (PO, Capsule)
- 28 Aug 2023 No recent reports of development identified for phase-I development in Solid-tumours(Inoperable/Unresectable, Late-stage disease, Metastatic disease) in Hong Kong (PO, Capsule)
- 28 Aug 2023 No recent reports of development identified for phase-I development in Solid-tumours(Inoperable/Unresectable, Late-stage disease, Metastatic disease) in South Korea (PO, Capsule)